Sumitomo Chemical India Ltd Q4 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/3nveoaepey5foynmucm1onmf.pdf

Key Takeaways


The FY24 Shock: What Happened

Chetan Shah: "So see, our first objective is not to match the numbers or surpass the numbers. What we are concentrating on is to increase the volumes of our products. Because as you may have noticed in order to compare the last year's numbers, the prices itself have dropped 25% or so, 25%, 30% in some products, even more maybe."

Margin Story: The Inventory Reset Payoff

Chetan Shah: "As of date, we don't intend to but we'll have to see the competition... Fortunately, we, at Sumitomo products, we don't have a high level of inventory in the market, which is another very good sign for us. So how much the competition will drop, we cannot judge as fully as of today. But what we have seen in Q4 and in the first month of Q1, is that it is not affecting us significantly. So I think it would be safe to presume and we hope that we don't have to reduce any more prices."

Manufacturing Expansion: The Parent's India Bet

Masanori Uzawa: "First of all, I would like to say the Sumitomo Chemical Tokyo's commitment to the India manufacturing is unwavering. So we have a strong commitment and that will never change."

Demand Recovery: Domestic First, Exports Later


Product Pipeline & Portfolio Shift


Guidance & Commitments

CommitmentSpecificsTimeline
Gross margin sustainabilityQ4 pricing carried into Q1, accepted by market; no risk of price reduction seenBarring monsoon failure or geopolitical shock
Bhavnagar plant export ramp-up100% of production capacity exported (up from 40–50%)FY25
Tarapur plant full production5 new molecules to reach fullest extent of commercial productionFY26 (delayed from FY25)
Dahej environmental clearanceApplication submitted; clearance expectedEnd of calendar year 2024
Dahej commercial production18–24 months after EC clearance and parent product approvalFY26–FY27
New Bhavnagar land contributionMeaningful contribution from 20-acre expansion12–18 months
Green energy capexINR25 crores to become 100% green power generation companyEnd of FY25
New product contribution aspiration8–10% of revenue from new productsIf monsoon is normal
Capex fundingAll capex funded from internal accruals, no external borrowingOngoing

Key Metrics

MetricQ4 FY24
Revenue₹674 cr, up 3% YoY and 24% QoQ
Gross margin41.7%, up 1,042 bps YoY and 199 bps QoQ
EBITDA₹140 cr, up 74% YoY and 113% QoQ
EBITDA margin20.8%, up 843 bps YoY
Profit after tax₹110 cr, up 52% YoY and 101% QoQ
PAT margin16.3%, up 523 bps YoY
FY24 full-year revenue₹2,844 cr, down 19% YoY from ₹3,511 cr
FY24 full-year EBITDA margin16.7%, vs 19% in FY23
FY24 full-year PAT₹370 cr, vs ₹502 cr in FY23
Domestic revenue share (FY24)~80% of total revenue, export ~20%
Insecticides share (FY24)~41% of total revenue
Herbicides share (FY24)~22% of total revenue
PGR share (FY24)~10% of total revenue
Fungicides share (FY24)~8% of total revenue
Cash and cash equivalents₹1,207 cr as on 31st March 2024, after interim dividend payment
Net working capital reduction33 days as on March 2024 vs March 2023
Collections (FY24)₹3,325 cr, down 9% vs ₹3,676 cr in FY23, against 19% revenue decline
Specialty volume degrowth (FY24)~8-9% overall, with minimal price decline of ~2%
New product contribution aspiration8-10% of revenue from products launched in the last 2-3 years
Barrix consolidated sales₹10-12 cr for ~105 days from 15 Dec 2023
Bhavnagar new plant capacity utilization (FY24)40-60% commercialization achieved, 100% expected in FY25
Maintenance and other capex planned (FY25)₹53 cr, including ₹25 cr for green energy to achieve 100% captive power
Next capex cycle estimate₹250-300 cr to start the new Dahej site, funded through internal accruals